• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Haemonetics Corp (NY: HAE )

    91.04 +0.44 (+0.49%)
    Streaming Delayed Price Updated: 12:09 PM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 73,748
    Open 91.15
    Bid (Size) 90.89 (2)
    Ask (Size) 91.19 (4)
    Prev. Close 90.60
    Today's Range 90.29 - 92.74
    52wk Range 70.74 - 97.97
    Shares Outstanding 51,029,618
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NYSE:HAE stands out as a growth opportunity that won't break the bank.
    NYSE:HAE is not too expensive for the growth it is showing. 
    Via Chartmill
    Looking for growth without the hefty price tag? Consider NYSE:HAE.
    HAEMONETICS CORP/MASS (NYSE:HAE) stands out as a growth opportunity that won't break the bank. 
    Via Chartmill

    Performance

    YTD
    +6.93%
    +6.93%
    1 Month
    +9.13%
    +9.13%
    3 Month
    +3.86%
    +3.86%
    6 Month
    +12.08%
    +12.08%
    1 Year
    -2.38%
    -2.38%

    More News

    Read More
    Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
    Via Benzinga
    This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
    Via Benzinga
    These 3 Companies Boast Bright Outlooks
    Via Talk Markets
    NYSE:HAE, a growth stock which is not overvalued.
    Via Chartmill
    4 Analysts Assess Haemonetics: What You Need To Know
    Via Benzinga
    Earnings Scheduled For February 8, 2024
    Via Benzinga
    Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
    Via InvestorPlace
    For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
    Via Chartmill
    Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
    Via Investor's Business Daily
    Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
    Via Investor's Business Daily
    Exploring NYSE:HAE's quality characteristics.
    Via Chartmill
    Should you consider NYSE:HAE for quality investing?
    Via Chartmill
    4 Analysts Have This to Say About Haemonetics
    Via Benzinga
    Haemonetics Earnings Preview
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
    Via Investor's Business Daily
    Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
    Via Benzinga
    Recap: Haemonetics Q4 Earnings
    Via Benzinga
    Looking Into Haemonetics's Return On Capital Employed
    Via Benzinga
    Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.